Chemical Formula: C20H23N7O7

Chemical Formula C20H23N7O7

Found 30 metabolite its formula value is C20H23N7O7

(6R)-Folinic acid

2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

C20H23N7O7 (473.1658888)


The active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. [HMDB] D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

   

10-Formyltetrahydrofolate

(2S)-2-[(4-{N-[(4-hydroxy-2-imino-5,6,7,8-tetrahydro-1H-pteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioic acid

C20H23N7O7 (473.1658888)


10-formyltetrahydrofolate, also known as 10-formyl-thf or 10-formyltetrahydropteroylglutamic acid, is a member of the class of compounds known as tetrahydrofolic acids. Tetrahydrofolic acids are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit. 10-formyltetrahydrofolate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). 10-formyltetrahydrofolate can be found in a number of food items such as agave, black salsify, white cabbage, and lemon, which makes 10-formyltetrahydrofolate a potential biomarker for the consumption of these food products. 10-formyltetrahydrofolate exists in all eukaryotes, ranging from yeast to humans. In humans, 10-formyltetrahydrofolate is involved in several metabolic pathways, some of which include mercaptopurine action pathway, methionine metabolism, purine metabolism, and folate malabsorption, hereditary. 10-formyltetrahydrofolate is also involved in several metabolic disorders, some of which include myoadenylate deaminase deficiency, adenine phosphoribosyltransferase deficiency (APRT), molybdenum cofactor deficiency, and cystathionine beta-synthase deficiency. 10-Formyltetrahydrofolate (10-CHO-THF) is a form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In these reactions 10-CHO-THF is used as a substrate in formyltransferase reactions. This is important in purine biosynthesis, where 10-CHO-THF is a substrate for phosphoribosylaminoimidazolecarboxamide formyltransferase, as well as in the formylation of the methionyl initiator tRNA (fMet-tRNA), when 10-CHO-THF is a substrate for methionyl-tRNA formyltransferase . 10-Formyltetrahydrofolate (10-CHO-THF) is form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In particular, 10-CHO-THF is used as a substrate in a number of formyltransferase reactions. It plays an important role in purine biosynthesis, where 10-CHO-THF is a substrate for phosphoribosylaminoimidazolecarboxamide formyltransferase, as well as in the formylation of the methionyl initiator tRNA (fMet-tRNA), when 10-CHO-THF is a substrate for methionyl-tRNA formyltransferase. 10-Formyltetrahydrofolate is a substrate for Trifunctional purine biosynthetic protein adenosine-3, Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), 10-formyltetrahydrofolate dehydrogenase, Folylpolyglutamate synthase (mitochondrial), Bifunctional purine biosynthesis protein PURH and C-1-tetrahydrofolate synthase (cytoplasmic).

   

Folinic acid

(2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioic acid

C20H23N7O7 (473.1658888)


(6S)-5-formyltetrahydrofolic acid is the pharmacologically active (6S)-stereoisomer of 5-formyltetrahydrofolic acid. It has a role as an antineoplastic agent and a metabolite. It is a conjugate acid of a (6S)-5-formyltetrahydrofolate(2-). Levoleucovorin is the enantiomerically active form of Folinic Acid (also known as 5-formyl tetrahydrofolic acid or leucovorin). Commercially available leucovorin is composed of a 1:1 racemic mixture of the dextrorotary and levorotary isomers, while levoleucovorin contains only the pharmacologically active levo-isomer. In vitro, the levo-isomer has been shown to be rapidly converted to the biologically available methyl-tetrahydrofolate form while the dextro form is slowly excreted by the kidneys. Despite this difference in activity, the two commercially available forms have been shown to be pharmacokinetically identical and may be used interchangeably with limited differences in efficacy or side effects (Kovoor et al, 2009). As folate analogs, levoleucovorin and leucovorin are both used to counteract the toxic effects of folic acid antagonists, such as methotrexate, which act by inhibiting the enzyme dihydrofolate reductase (DHFR). They are indicated for use as rescue therapy following use of high-dose methotrexate in the treatment of osteosarcoma or for diminishing the toxicity associated with inadvertent overdosage of folic acid antagonists. Levoleucovorin, as the product Fusilev (FDA), has an additional indication for use in combination chemotherapy with 5-fluorouracil in the palliative treatment of patients with advanced metastatic colorectal cancer. Folic acid is an essential B vitamin required by the body for the synthesis of purines, pyrimidines, and methionine before incorporation into DNA or protein. However, in order to function in this role, it must first be reduced by the enzyme dihydrofolate reductase (DHFR) into the cofactors dihydrofolate (DHF) and tetrahydrofolate (THF). This important pathway, which is required for de novo synthesis of nucleic acids and amino acids, is disrupted when high-dose methotrexate is used for cancer therapy. As methotrexate functions as a DHFR inhibitor to prevent DNA synthesis in rapidly dividing cells, it also prevents the formation of DHF and THF. This results in a deficiency of coenzymes and a resultant buildup of toxic substances that are responsible for numerous adverse side effects of methotrexate therapy. As levoleucovorin and leucovorin are analogs of tetrahydrofolate (THF), they are able to bypass DHFR reduction and act as a cellular replacement for the co-factor THF, thereby preventing these toxic side effects. Levoleucovorin is a Folate Analog. Levoleucovorin is a natural product found in Homo sapiens with data available. Levoleucovorin is the active l-isomer of the racemic mixture of the 5-formyl derivative of tetrahydrofolic acid. Metabolically active, l-leucovorin, also known levoleucovorin, does not require bioactivation by dihydrofolate reductase, an enzyme inhibited by folic acid antagonists. This agent may enhance the effects of fluoropyrimidines by stabilizing their binding to the enzyme thymidylate synthase. (NCI04) 5-Formyltetrahydrofolic acid is a metabolite found in or produced by Saccharomyces cerevisiae. A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN. See also: Levoleucovorin Calcium (active moiety of); Levoleucovorin disodium (active moiety of). Folinic acid (CAS: 58-05-9), also known as leucovorin, is a medication used to decrease the toxic effects of methotrexate (a chemotherapy agent and immune system suppressant) and pyrimethamine (Wikipedia). Folinic acid is the active metabolite of folic acid. Leucovorin is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

   

Pteroyl-D-glutamic acid

(2R)-2-[(4-{[(2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid

C20H23N7O7 (473.1658888)


The active metabolite of Folic acid, is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid. Folic acid, a water-soluble B-complex vitamin, is found in foods such as liver, kidneys, yeast, and leafy, green vegetables. Folic acid is used to diagnose folate deficiency and to treat topical sprue and megaloblastic and macrocytic anemias, hematologic complications resulting from a deficiency in folic acid. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (poaceae). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. The active metabolite of Folic acid, is used principally as its calcium salt as an antidote to folic acid antagonists which block the conversion of folic acid to folinic acid.

   

Mefox

2-({4-[({2-amino-8-methyl-4,9-dioxo-4H,6H,7H,8H,9H-pyrazino[1,2-a][1,3,5]triazin-7-yl}methyl)amino]phenyl}formamido)pentanedioic acid

C20H23N7O7 (473.1658888)


   

Formyltetrahydrofolate

2-[(4-{[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methyl]amino}phenyl)formamido]-5-(formyloxy)-5-oxopentanoic acid

C20H23N7O7 (473.1658888)


   

2-[[4-[(2-Amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-formylpentanedioic acid

2-[(4-{[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methyl]amino}phenyl)formamido]-4-formylpentanedioic acid

C20H23N7O7 (473.1658888)


   

Folinic acid

(6R)-Folinic acid

C20H23N7O7 (473.1658888)


Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

   

Folinic acid; AIF; CE0; CorrDec

Folinic acid; AIF; CE0; CorrDec

C20H23N7O7 (473.1658888)


   

Folinic acid; AIF; CE10; CorrDec

Folinic acid; AIF; CE10; CorrDec

C20H23N7O7 (473.1658888)


   

Folinic acid; AIF; CE30; CorrDec

Folinic acid; AIF; CE30; CorrDec

C20H23N7O7 (473.1658888)


   

Folinic acid; AIF; CE0; MS2Dec

Folinic acid; AIF; CE0; MS2Dec

C20H23N7O7 (473.1658888)


   

Folinic acid; AIF; CE10; MS2Dec

Folinic acid; AIF; CE10; MS2Dec

C20H23N7O7 (473.1658888)


   

Folinic acid; AIF; CE30; MS2Dec

Folinic acid; AIF; CE30; MS2Dec

C20H23N7O7 (473.1658888)


   

Folinic acid; LC-tDDA; CE10

Folinic acid; LC-tDDA; CE10

C20H23N7O7 (473.1658888)


   

Folinic acid; LC-tDDA; CE20

Folinic acid; LC-tDDA; CE20

C20H23N7O7 (473.1658888)


   

Folinic acid; LC-tDDA; CE30

Folinic acid; LC-tDDA; CE30

C20H23N7O7 (473.1658888)


   

Folinic acid; LC-tDDA; CE40

Folinic acid; LC-tDDA; CE40

C20H23N7O7 (473.1658888)


   

Pteroyl-D-glutamic acid

Pteroyl-D-glutamic acid

C20H23N7O7 (473.1658888)


   

N-[4-[[(2-Amino-6,7,8,9-tetrahydro-8-methyl-4,9-dioxo-4H-pyrazino[1,2-a]-1,3,5-triazin-7-yl)methyl]amino]benzoyl]-L-glutamic Acid

N-[4-[[(2-Amino-6,7,8,9-tetrahydro-8-methyl-4,9-dioxo-4H-pyrazino[1,2-a]-1,3,5-triazin-7-yl)methyl]amino]benzoyl]-L-glutamic Acid

C20H23N7O7 (473.1658888)


   

leucovorin

Folinic acid

C20H23N7O7 (473.1658888)


D020011 - Protective Agents > D000931 - Antidotes C2140 - Adjuvant > C2078 - Folic Acid Derivative D018977 - Micronutrients > D014815 - Vitamins Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1].

   

5-Hydroxymethylene-6-hydrofolic acid

5-Hydroxymethylene-6-hydrofolic acid

C20H23N7O7 (473.1658888)


   

10-Formyltetrahydropteroylglutamic acid

10-Formyltetrahydropteroylglutamic acid

C20H23N7O7 (473.1658888)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Formyltetrahydrofolate

Formyltetrahydrofolate

C20H23N7O7 (473.1658888)


   

N-{4-[{[(6s)-2-Amino-4-Oxo-3,4,5,6,7,8-Hexahydropteridin-6-Yl]methyl}(Formyl)amino]benzoyl}-L-Glutamic Acid

N-{4-[{[(6s)-2-Amino-4-Oxo-3,4,5,6,7,8-Hexahydropteridin-6-Yl]methyl}(Formyl)amino]benzoyl}-L-Glutamic Acid

C20H23N7O7 (473.1658888)


   

N-(10-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid

N-(10-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid

C20H23N7O7 (473.1658888)


   

5-Formyltetrahydrofolic acid

5-Formyltetrahydrofolic acid

C20H23N7O7 (473.1658888)


A formyltetrahydrofolic acid in which the formyl group is located at position 5.

   

(6S)-10-formyltetrahydrofolic acid

(6S)-10-formyltetrahydrofolic acid

C20H23N7O7 (473.1658888)


A 10-formyltetrahydrofolic acid that has S-configuration at position 6.

   

(6S)-5-formyltetrahydrofolic acid

(6S)-5-formyltetrahydrofolic acid

C20H23N7O7 (473.1658888)


The pharmacologically active (6S)-stereoisomer of 5-formyltetrahydrofolic acid.

   

(6R)-10-formyltetrahydrofolic acid

(6R)-10-formyltetrahydrofolic acid

C20H23N7O7 (473.1658888)


A 10-formyltetrahydrofolic acid that has R-configuration at position 6.